Géric Maura

Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases

Sudha R. Raman, Kenneth K. C. Man, Shahram Bahmanyar et al. · The Lancet Psychiatry · 2018 · 312 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +14

Comparison of the Short-Term Risk of Bleeding and Arterial Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Newly Treated With Dabigatran or Rivaroxaban Versus Vitamin K Antagonists

Géric Maura, Pierre‐Olivier Blotière, Kim Bouillon et al. · Circulation · 2015 · 167 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study

Kim Bouillon, Marion Bertrand, Géric Maura et al. · The Lancet Haematology · 2015 · 95 citations

Medicine, Cardiology, Pharmacotherapy +17

Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data

Stéphanie Foulon, Géric Maura, Marie Dalichampt et al. · Journal of Neurology · 2017 · 67 citations · Full text

Medicine, Health Policy, Neurology +14

Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a <scp>F</scp>rench nationwide cohort study

Géric Maura, François Alla, Cécile Billionnet · Pharmacoepidemiology and Drug Safety · 2017 · 67 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17